Immunohistochemical and Serological 90K / Mac-2BP Detection in Hepatocellular Carcinoma Patients: Different Behaviour of Two Monoclonal Antibodies

A.   M.   Valentini; P.   A.   Iacovazzi; M.      Correale; M.      Pirrelli; R.      Armentano; S.      Iacobelli; N.      Tinari; I.      Iurisci; M.   L.   Caruso

doi:10.2174/1573406053175229

Abstract

To clarify the biological role of the 90K/Mac-2BP glycoprotein, we evaluated the ability of two MAbs SP-2 and 1A4.22, to reveal this glycoprotein in both serum and tissue from hepatocellular carcinoma (HCC) patients. Tissue expression of 90K was detected by the immunohistochemical method in 20 HCC patients, while the 90K serum level was assessed by the ELISA assay in 13 HCC patients. MAb SP-2 was reactive only in serum, with a mean value of 12.8± 6.7 μg/ml . On the contrary, MAb 1A4.22 revealed immunoreactivity both in 92% of sera and in 60% of neoplastic samples. Positive staining was seen only in the epithelial cells and was cytoplasmic and granular in all instances. The mean 90K serum level assayed with MAb 1A4.22 was 29.4 ± 13.7 μg/ml. .Patients with a 90K serum level ≤ 30 mg/ml had positive tissue samples in 71% of cases versus 20% of patients with a serum level > 30 μg/ml. Moreover, a possible poor prognostic role was observed for negative 90K in tissue. Our results suggest that only MAb 1A4.22 could demonstrate 90K glycoprotein expression in paraffin-embedded tissue and that this MAb could have a diagnostic and prognostic role in both sera and tissues from HCC patients.

Keywords: 90k, mab sp-2, mab 1a4.22, hcc

« Previous Next »